ACP5 and osteoporosis: ICT significantly inhibited OC differentiation and the expression of related genes (Trap, Mmp9, and Nfatc1), reduced bone loss, and improved osteoporosis and bone trabecular structure, and inhibited the levels of TRAP and RANKL in the serum and increase the level of osteoprotegerin (OPG).